• Study on Shortened Antibiotic Treatment for Infectious Endocarditis Using Vancomycin, Meropenem, and Ceftriaxone for Patients with Left-Sided Heart Infection

    Recruiting

    3 1 1 1
    Investigated diseases:
    Sweden
  • Study on [68Ga]FAPI-46 to Detect Fibroblast Activity in Patients with Non-Resolving Acute Respiratory Distress Syndrome (ARDS) in the ICU

    Recruiting

    3 1 1
    Investigated diseases:
    The Netherlands
  • Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Poland Romania Slovakia Spain
  • Study Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study on Zinc Acexamate for Patients with Advanced Chronic Liver Disease

    Recruiting

    3 1 1
    Investigated drugs:
    Spain
  • Study on Everolimus and Drug Combination for Children with Relapsed or Refractory Pediatric Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Denmark France Italy The Netherlands Spain
  • Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany Greece Hungary Italy Spain
  • Study on Opioid Detoxification Using Buprenorphine, Naloxone, and Oxycodone for Patients with Persistent Spinal Pain Syndrome Type II

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • A Study of Dabrafenib and Trametinib Treatment Before and After Surgery in Patients with Papillary Craniopharyngioma

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study on Treatments for Intermediate High-Risk Pulmonary Embolism: Comparing Percutaneous Embolectomy, Ultrasound-Assisted Thrombolysis with Alteplase, and Heparin

    Recruiting

    3 1 1 1
    Denmark

powered by